Clinical Trial Update: AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating AR-42 in combination with decitabine for adults with acute myeloid leukemia across multiple cytogenetic subtypes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia De Novo
• Acute Myeloid Leukemia Recurrent
• Acute Myeloid Leukemia Secondary
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Abnormality
• Acute Myeloid Leukemia with Deletion 5q
• Acute Myeloid Leukemia with Inv

Drugs mentioned

• AR-42 (AR-42)
• Decitabine (Decitabine)

Snippet

Sponsor: Alison Walker | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 1 | Status: COMPLETED